Edgewise Reports Positive Phase 2 EDG-7500 HCM Data
BOULDER, Colo., June 16, 2026 Edgewise Therapeutics has announced positive top-line results from the 12-week Phase 2 CIRRUS-HCM trial...
clinical decision support
Advertisement
Castle TissueCypher Surpasses 100,000 Orders in Barrett’s
FRIENDSWOOD, Texas, June 16, 2026 Castle Biosciences has announced that its TissueCypher® Barrett’s Esophagus Test has surpassed 100,000 clinical...
Philips Finds AI Boosting Patient Access and Clinical Efficiency Worldwide
AMSTERDAM, Netherlands, June 9, 2026 Artificial intelligence is already delivering measurable benefits across healthcare systems, saving clinicians the equivalent...
GSK’s Bepirovirsen Delivers Landmark Phase 3 Cure Data
LONDON, UK, May 28, 2026 GSK has announced groundbreaking Phase III clinical trial results for bepirovirsen, its investigational antisense...
Callio Therapeutics Advances CLIO-8221 Phase 1 Trial for HER2 Tumors
SEATTLE and SINGAPORE, May 27, 2026 Callio Therapeutics has announced the presentation of its Phase 1 clinical trial design...
Advertisements
Roche Launches AI-Powered Liver Disease Panel for Early Detection
BASEL, Switzerland, May 27, 2026 Roche has announced the launch of its groundbreaking Liver Disease Panel, the healthcare industry’s...
Remepy Reports Strong Hybridopa Parkinson’s Trial Data
NEW YORK, N.Y., May 20, 2026 Remepy has announced positive results from its Phase IIa clinical trial evaluating Hybridopa™,...
Optimi Health Prices $15M Nasdaq Uplisting Offering
VANCOUVER, British Columbia, May 20, 2026 Optimi Health Corp. has announced the pricing of an oversubscribed US$15 million underwritten...
Paragon Institute Proposes Safer Future for AI Medical Devices
BOSTON, Mass., May 20, 2026 The Paragon Institute has released a new scientific proposal highlighting the growing risks associated...
FDB Study Shows 70% Drop in Pharmacy Alerts
SOUTH SAN FRANCISCO, Calif., May 15, 2026 FDB (First Databank) announced new research findings at the AMIA Amplify Informatics...
Advertisement
